Search Results - "Egeli, U."

Synthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cancer by Guney Eskiler, G., Cecener, G., Egeli, U., Tunca, B.

Get full text

Association BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer by Guney Eskiler, G., Cecener, G., Egeli, U., Tunca, B.

Get full text

The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma by Yurdacan, B, Egeli, U, Eskiler, G Guney, Eryilmaz, I E, Cecener, G, Tunca, B

“…Usnic acid (UA) is a multifunctional bioactive lichen secondary metabolite with potential anti-cancer properties. Although the promising therapeutic effects of…”
Get more information

Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus–Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation by Dundar, H.Z., Aksoy, F., Aksoy, S. Ak, Tasar, P., Ugras, N., Tunca, B., Egeli, U., Cecener, G., Yerci, O., Kaya, E.

“…Liver transplantation (LT) is the best treatment option for hepatitis B virus (HBV)–mediated hepatocellular carcinoma (HCC). Nevertheless, recurrence is the…”
Get full text

Oleuropein modulates glioblastoma miRNA pattern different from Olea europaea leaf extract by Tezcan, G, Aksoy, S A, Tunca, B, Bekar, A, Mutlu, M, Cecener, G, Egeli, U, Kocaeli, H, Demirci, H, Taskapilioglu, M O

“…Glioblastoma (GBM) is the most prevalent and deadliest subtype of glioma. Despite current innovations in existing therapeutic modalities, GBM remains…”
Get more information

Cancer stem cell markers in pancreatic ductal adenocarcinoma by Aksoy, F., Kaya, E., Egeli, U., Dundar, H.Z., Tasar, P., Aksoy, S.A., Ozen, Y., Tunca, B., Cecener, G., Yerci, O.

Get full text

The cytotoxic effect of usnic acid in malignant melanoma cells with different genomic profiles in the BRAF aspect by C. Çolakoglu, A. Haciefendi, I. Eryilmaz, G. Eskiler, U. Egeli, G. Cecener

“…Objective: Malignant melanoma (MM) is the most aggressive skin cancer and treatment options are still limited in the late stages, generally accompanied by BRAF…”
Get full text

Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey by Cecener, G., Guney Eskiler, G., Egeli, U., Tunca, B., Alemdar, A., Gokgoz, S., Tasdelen, I.

“…The PALB2 gene, has been accepted as a moderate-penetrance gene associated with breast cancer susceptibility and this gene product is involved in the DNA…”
Get full text

759: Ficus carica latex inhibits GBM cell proliferation by modulating let-7d expression by Tezcan, G, Tunca, B, Bekar, A, Cecener, G, Egeli, U, Malyer, H

Get full text

A novel [Mn2(μ-(C6H5)2CHCOO)2(bipy)4](bipy)(ClO4)2 complex loaded solid lipid nanoparticles: synthesis, characterization and in vitro cytotoxicity on MCF-7 breast cancer cells by Guney Eskiler, G., Cecener, G., Dikmen, G., Kani, I., Egeli, U., Tunca, B.

“…Manganese (Mn)-based complexes have been drawing attention due to the fact that they are more effective than other metal complexes. However, the use of…”
Get full text

564: The expression level of MACC1 in early stage CRC patients of Turkish population by Ceylan, S, Ak, S, Tunca, B, Ozturk, E, Tezcan, G, Cecener, G, Egeli, U, Yilmazlar, T, Yerci, O

Get full text

398: Evaluation of microRNA expression profiles in triple-negative (ER, PR and Her2/neu) breast cancer patients with and without germ-line BRCA mutations by Erturk, E, Cecener, G, Egeli, U, Tunca, B, Tezcan, G, Gokgoz, S, Tolunay, S, Tasdelen, I

Get full text

271 Alterations of MiRNA Expression in Early-onset Turkish Colorectal Cancer Patients' Tumor Tissues by Ak, S, Tunca, B, Cecener, G, Egeli, U, Tezcan, G, Zorluoglu, A, Yilmazlar, T, Ozturk, E, Yerci, O, Evrensel, T

Get full text

436 Evaluating of BRCA1 and BRCA2 Germ-line Mutations and BRCA Risk Assessment of Mutation Carriers in Turkish Breast Cancer Patients by Cecener, G, Egeli, U, Tunca, B, Erturk, E, Gokgoz, S, Tasdelen, I, Ak, S, Demirdogen, E, Tezcan, G, Bayram, N

Get full text

426 Distinct MiRNA Expression Patterns in Among Breast Tumors of Patients Carried and Non-carried Germ-line BRCA Mutations by Erturk, E, Cecener, G, Tunca, B, Egeli, U, Tezcan, G, Gokgoz, S, Tasdelen, I, Tolunay, S, Alder, H, Huebner, K

Get full text

Investigation of c-myc and p53 gene alterations in the tumor and surgical borderline tissues of NSCLC and effects on clinicopathologic behavior: by the FISH technique by Yakut, T, Egeli, U, Gebitekin, C

“…Genetic alterations on the primary tumoral tissues and surgical borderline tissues of 51 patients with NSCLC on which radiotherapy and chemotherapy had not…”
Get full text

P138 The effect of BRAF inhibitor Encorafenib on cell migration and invasion ability in the BRAF-mutant metastatic castration-resistant prostate cancer cells by Eryilmaz, I.E., Colakoglu Bergel, C., Arioz, B., Egeli, U.

Get full text

75PSynthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cancer by Guney Eskiler, G, Cecener, G, Egeli, U, Tunca, B

Get full text

67PAssociation BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer by Guney Eskiler, G, Cecener, G, Egeli, U, Tunca, B

Get full text

Cytogenetic results of amniocentesis materials: incidence of abnormal karyotypes in the Turkish collaborative study by Karaoguz, M Yirmibes, Bal, F, Yakut, T, Ercelen, N Ozturk, Ergun, M A, Gokcen, A Balci, Biri, A Asyali, Kimya, Y, Urman, B, Gultomruk, M, Egeli, U, Menevse, S

“…The experience on prenatal chromosome diagnosis of four Turkish centers participating in a collaborative study on 6041 genetic amniocentesis performed during a…”
Get more information